✦ LIBER ✦

Bevacizumab in HER2-negative non-metastatic breast cancer

✍ Scribed by Neil Bennet

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in combination with paclitax

✍ Konstantin J. Dedes; Klazien Matter-Walstra; Matthias Schwenkglenks; Bernhard C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 718 KB

Paclitaxel and bevacizumab in first-line

✍ Lorenzo Livi, Pierluigi Bonomo, Icro Meattini, Gabriele Simontacchi, Daniela Gre 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 170 KB

HER2 overexpressing metastatic breast ca

✍ David R. Spigel; Harold J. Burstein 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 399 KB

Metronomic Chemotherapy Combined With Be

✍ Emilia Montagna; Giuseppe Cancello; Vincenzo Bagnardi; Davide Pastrello; Silvia 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 488 KB

Current approaches to the management of

✍ Keerthi Gogineni; Angela DeMichele 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 296 KB

State of the art therapy for HER2-negati

✍ Laura Biganzoli 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 151 KB